COO vs STRO · P/E 36, rev $4.09B vs rev $62.0M
The Cooper Companies, Inc (COO) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. Revenue was up 5.1% from 2024-10-31 to 2025-10-31. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
COO currently screens at market cap $14.92B and trailing P/E 36.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the COO and STRO stock pages for the full models.
Not investment advice.